Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urticaria and Angioedema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04654351
What this trial is testing

Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 2
Not applicableNot Yet RecruitingNCT07445087
What this trial is testing

Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 35
Not applicableStudy completedNCT01397864
What this trial is testing

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 181
Large-scale testing (Phase 3)Study completedNCT00289211
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 83
Testing effectiveness (Phase 2)Looking for participantsNCT07046806
What this trial is testing

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

Who this might be right for
Hereditary Angioedema (HAE)AngioedemaBradykinin-mediated Angioedema+1 more
Institute for Asthma and Allergy 10
Large-scale testing (Phase 3)Study completedNCT06467084
What this trial is testing

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 36
Not applicableStudy completedNCT05509569
What this trial is testing

A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 32
Not applicableLooking for participantsNCT07021495
What this trial is testing

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more
Leiden University Medical Center 840
Not applicableStudy completedNCT05147181
What this trial is testing

A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 48
Post-approval studies (Phase 4)Study completedNCT03576469
What this trial is testing

Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions

Who this might be right for
CVI - Common Variable Immunodeficiency
IMMUNOe Research Centers 20
Early research (Phase 1)Study completedNCT00432510
What this trial is testing

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

Who this might be right for
Hereditary Angioedema
Shire 27
Not applicableStudy completedNCT02826356
What this trial is testing

Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema

Who this might be right for
ACE-I and ARB-induced Angioedema.
Hospices Civils de Lyon 38
Large-scale testing (Phase 3)Study completedNCT05032157
What this trial is testing

Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 455
Not applicableLooking for participantsNCT06782230
What this trial is testing

ScATtEred Rare Disease Biobanks: a Model of Sample/Data Collection With susTainablE and Shared Criteria

Who this might be right for
Creation of an Italian Network of Biobanks of Rare Diseases
IRCCS Policlinico S. Donato 800
Not applicableNo Longer AvailableNCT04583007
What this trial is testing

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

Who this might be right for
Hereditary Angioedema (HAE)Angioedema
Shire
Not applicableActive Not RecruitingNCT05397431
What this trial is testing

A Survey of Lanadelumab in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 155
Testing effectiveness (Phase 2)Study completedNCT03926611
What this trial is testing

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 311
Post-approval studies (Phase 4)Study completedNCT06806657
What this trial is testing

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

Who this might be right for
Hereditary Angioedema
CSL Behring 18
Not applicableLooking for participantsNCT07001280
What this trial is testing

A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedemas
CSL Behring 200
Testing effectiveness (Phase 2)Study completedNCT04307381
What this trial is testing

An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc. 20
Next Page